Industry: Medical Devices & Consumables
Published Date: 2025-01-18
Pages: 94 Pages
Report ld: 3439167
Request Sample
Customized Report
Percutaneous Mechanical Circulatory Support Devices Market Size(US$)

CAGR 2025-2031
4.8%
Market Size,2031
USD 2,740
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Percutaneous Mechanical Circulatory Support Devices was estimated to be worth US$ 1984 million in 2024 and is forecast to a readjusted size of US$ 2740 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Percutaneous mechanical circulatory support (PMCS) is a "bridge" technology to wait for cardiac function recovery or to buy time for subsequent treatment, because it is effective in treating patients with cardiac shock or acute decompensated heart failure in the acute stage.
The core global manufacturers of percutaneous mechanical circulatory support devices include MC3 Cardiopulmonary, LivaNova, Procyrion, Getinge, Terumo and Fresenius Medical Care. The top three manufacturers account for approximately 78% of the global share. Abiomed is the world's largest manufacturer of percutaneous mechanical circulatory support devices, with approximately 56% market share.
North America is the world's largest market, accounting for nearly 60% of the market share. The second and third places are Europe and Asia-Pacific, accounting for 23% and 10% respectively.
In terms of product type, Impella occupies a dominant position with a 92% share. At the same time, in terms of applications, hospitals are the largest application field, accounting for 88%.
This report aims to provide a comprehensive presentation of the global market for Percutaneous Mechanical Circulatory Support Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Percutaneous Mechanical Circulatory Support Devices by region & country, by Type, and by Application.
The Percutaneous Mechanical Circulatory Support Devices market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Percutaneous Mechanical Circulatory Support Devices.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Percutaneous Mechanical Circulatory Support Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Percutaneous Mechanical Circulatory Support Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Percutaneous Mechanical Circulatory Support Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Percutaneous Mechanical Circulatory Support Devices Product Introduction
1.2 Global Percutaneous Mechanical Circulatory Support Devices Market Size Forecast
1.2.1 Global Percutaneous Mechanical Circulatory Support Devices Sales Value (2020-2031)
1.2.2 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume (2020-2031)
1.2.3 Global Percutaneous Mechanical Circulatory Support Devices Sales Price (2020-2031)
1.3 Percutaneous Mechanical Circulatory Support Devices Market Trends & Drivers
1.3.1 Percutaneous Mechanical Circulatory Support Devices Industry Trends
1.3.2 Percutaneous Mechanical Circulatory Support Devices Market Drivers & Opportunity
1.3.3 Percutaneous Mechanical Circulatory Support Devices Market Challenges
1.3.4 Percutaneous Mechanical Circulatory Support Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Percutaneous Mechanical Circulatory Support Devices Players Revenue Ranking (2024)
2.2 Global Percutaneous Mechanical Circulatory Support Devices Revenue by Company (2020-2025)
2.3 Global Percutaneous Mechanical Circulatory Support Devices Players Sales Volume Ranking (2024)
2.4 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume by Company Players (2020-2025)
2.5 Global Percutaneous Mechanical Circulatory Support Devices Average Price by Company (2020-2025)
2.6 Key Manufacturers Percutaneous Mechanical Circulatory Support Devices Manufacturing Base and Headquarters
2.7 Key Manufacturers Percutaneous Mechanical Circulatory Support Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Percutaneous Mechanical Circulatory Support Devices
2.9 Percutaneous Mechanical Circulatory Support Devices Market Competitive Analysis
2.9.1 Percutaneous Mechanical Circulatory Support Devices Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Percutaneous Mechanical Circulatory Support Devices Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Mechanical Circulatory Support Devices as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Extracorporeal Membrane Oxygenation Device (ECMO)
3.1.2 Intra-Aortic Balloon Pump (IABP)
3.1.3 Impella
3.1.4 Others
3.2 Global Percutaneous Mechanical Circulatory Support Devices Sales Value by Type
3.2.1 Global Percutaneous Mechanical Circulatory Support Devices Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Percutaneous Mechanical Circulatory Support Devices Sales Value, by Type (2020-2031)
3.2.3 Global Percutaneous Mechanical Circulatory Support Devices Sales Value, by Type (%) (2020-2031)
3.3 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume by Type
3.3.1 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume, by Type (2020-2031)
3.3.3 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume, by Type (%) (2020-2031)
3.4 Global Percutaneous Mechanical Circulatory Support Devices Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialized Cardiac Centers
4.1.3 Ambulatory Surgery centers
4.2 Global Percutaneous Mechanical Circulatory Support Devices Sales Value by Application
4.2.1 Global Percutaneous Mechanical Circulatory Support Devices Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Percutaneous Mechanical Circulatory Support Devices Sales Value, by Application (2020-2031)
4.2.3 Global Percutaneous Mechanical Circulatory Support Devices Sales Value, by Application (%) (2020-2031)
4.3 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume by Application
4.3.1 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume, by Application (2020-2031)
4.3.3 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume, by Application (%) (2020-2031)
4.4 Global Percutaneous Mechanical Circulatory Support Devices Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Percutaneous Mechanical Circulatory Support Devices Sales Value by Region
5.1.1 Global Percutaneous Mechanical Circulatory Support Devices Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Percutaneous Mechanical Circulatory Support Devices Sales Value by Region (2020-2025)
5.1.3 Global Percutaneous Mechanical Circulatory Support Devices Sales Value by Region (2026-2031)
5.1.4 Global Percutaneous Mechanical Circulatory Support Devices Sales Value by Region (%), (2020-2031)
5.2 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume by Region
5.2.1 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume by Region (2020-2025)
5.2.3 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume by Region (2026-2031)
5.2.4 Global Percutaneous Mechanical Circulatory Support Devices Sales Volume by Region (%), (2020-2031)
5.3 Global Percutaneous Mechanical Circulatory Support Devices Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
5.4.2 North America Percutaneous Mechanical Circulatory Support Devices Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
5.5.2 Europe Percutaneous Mechanical Circulatory Support Devices Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
5.6.2 Asia Pacific Percutaneous Mechanical Circulatory Support Devices Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
5.7.2 South America Percutaneous Mechanical Circulatory Support Devices Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
5.8.2 Middle East & Africa Percutaneous Mechanical Circulatory Support Devices Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Percutaneous Mechanical Circulatory Support Devices Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Percutaneous Mechanical Circulatory Support Devices Sales Value
6.2.1 Key Countries/Regions Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
6.2.2 Key Countries/Regions Percutaneous Mechanical Circulatory Support Devices Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
6.3.2 United States Percutaneous Mechanical Circulatory Support Devices Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Percutaneous Mechanical Circulatory Support Devices Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
6.4.2 Europe Percutaneous Mechanical Circulatory Support Devices Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Percutaneous Mechanical Circulatory Support Devices Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
6.5.2 China Percutaneous Mechanical Circulatory Support Devices Sales Value by Type (%), 2024 VS 2031
6.5.3 China Percutaneous Mechanical Circulatory Support Devices Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
6.6.2 Japan Percutaneous Mechanical Circulatory Support Devices Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Percutaneous Mechanical Circulatory Support Devices Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
6.7.2 South Korea Percutaneous Mechanical Circulatory Support Devices Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Percutaneous Mechanical Circulatory Support Devices Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
6.8.2 Southeast Asia Percutaneous Mechanical Circulatory Support Devices Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Percutaneous Mechanical Circulatory Support Devices Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Percutaneous Mechanical Circulatory Support Devices Sales Value, 2020-2031
6.9.2 India Percutaneous Mechanical Circulatory Support Devices Sales Value by Type (%), 2024 VS 2031
6.9.3 India Percutaneous Mechanical Circulatory Support Devices Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 MC3 Cardiopulmonary
7.1.1 MC3 Cardiopulmonary Company Information
7.1.2 MC3 Cardiopulmonary Introduction and Business Overview
7.1.3 MC3 Cardiopulmonary Percutaneous Mechanical Circulatory Support Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 MC3 Cardiopulmonary Percutaneous Mechanical Circulatory Support Devices Product Offerings
7.1.5 MC3 Cardiopulmonary Recent Development
7.2 LivaNova
7.2.1 LivaNova Company Information
7.2.2 LivaNova Introduction and Business Overview
7.2.3 LivaNova Percutaneous Mechanical Circulatory Support Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 LivaNova Percutaneous Mechanical Circulatory Support Devices Product Offerings
7.2.5 LivaNova Recent Development
7.3 Procyrion
7.3.1 Procyrion Company Information
7.3.2 Procyrion Introduction and Business Overview
7.3.3 Procyrion Percutaneous Mechanical Circulatory Support Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Procyrion Percutaneous Mechanical Circulatory Support Devices Product Offerings
7.3.5 Procyrion Recent Development
7.4 Getinge
7.4.1 Getinge Company Information
7.4.2 Getinge Introduction and Business Overview
7.4.3 Getinge Percutaneous Mechanical Circulatory Support Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Getinge Percutaneous Mechanical Circulatory Support Devices Product Offerings
7.4.5 Getinge Recent Development
7.5 Terumo
7.5.1 Terumo Company Information
7.5.2 Terumo Introduction and Business Overview
7.5.3 Terumo Percutaneous Mechanical Circulatory Support Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Terumo Percutaneous Mechanical Circulatory Support Devices Product Offerings
7.5.5 Terumo Recent Development
7.6 Fresenius Medical Care
7.6.1 Fresenius Medical Care Company Information
7.6.2 Fresenius Medical Care Introduction and Business Overview
7.6.3 Fresenius Medical Care Percutaneous Mechanical Circulatory Support Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Fresenius Medical Care Percutaneous Mechanical Circulatory Support Devices Product Offerings
7.6.5 Fresenius Medical Care Recent Development
7.7 Teleflex
7.7.1 Teleflex Company Information
7.7.2 Teleflex Introduction and Business Overview
7.7.3 Teleflex Percutaneous Mechanical Circulatory Support Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Teleflex Percutaneous Mechanical Circulatory Support Devices Product Offerings
7.7.5 Teleflex Recent Development
7.8 Senko Medical Instrument
7.8.1 Senko Medical Instrument Company Information
7.8.2 Senko Medical Instrument Introduction and Business Overview
7.8.3 Senko Medical Instrument Percutaneous Mechanical Circulatory Support Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Senko Medical Instrument Percutaneous Mechanical Circulatory Support Devices Product Offerings
7.8.5 Senko Medical Instrument Recent Development
7.9 Abiomed
7.9.1 Abiomed Company Information
7.9.2 Abiomed Introduction and Business Overview
7.9.3 Abiomed Percutaneous Mechanical Circulatory Support Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Abiomed Percutaneous Mechanical Circulatory Support Devices Product Offerings
7.9.5 Abiomed Recent Development
8 Industry Chain Analysis
8.1 Percutaneous Mechanical Circulatory Support Devices Industrial Chain
8.2 Percutaneous Mechanical Circulatory Support Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Percutaneous Mechanical Circulatory Support Devices Sales Model
8.5.2 Sales Channel
8.5.3 Percutaneous Mechanical Circulatory Support Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Percutaneous Mechanical Circulatory Support Devices market size was US$ 2069 million in 2025 and is forecast to reach a readjusted size of US$ 2858 million by 2032 with a CAGR of 4.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
The global Percutaneous Mechanical Circulatory Support Devices market was valued at US$ 2069 million in 2025 and is anticipated to reach US$ 2858 million by 2032, at a CAGR of 4.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 113
USD 2900.00
(Single User License)
The global market for Percutaneous Mechanical Circulatory Support Devices was estimated to be worth US$ 2069 million in 2025 and is projected to reach US$ 2858 million, growing at a CAGR of 4.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 3950.00
(Single User License)
The global Percutaneous Mechanical Circulatory Support Devices market size was US$ 1984 million in 2024 and is forecast to a readjusted size of US$ 2740 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 80
USD 4250.00
(Single User License)
The global Percutaneous Mechanical Circulatory Support Devices market is projected to grow from US$ 1984 million in 2024 to US$ 2740 million by 2031, at a CAGR of 4.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-08
Pages: 136
USD 4900.00
(Single User License)
The global Percutaneous Mechanical Circulatory Support Devices market is projected to grow from US$ 2069 million in 2025 to US$ 2740 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.
Published Date: 2025-04-14
Pages: 137
USD 4900.00
(Single User License)
The global market for Percutaneous Mechanical Circulatory Support Devices was estimated to be worth US$ 1984 million in 2024 and is forecast to a readjusted size of US$ 2740 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published Date: 2025-04-14
Pages: 94
USD 3950.00
(Single User License)
The global market for Percutaneous Mechanical Circulatory Support Devices was valued at US$ 1984 million in the year 2024 and is projected to reach a revised size of US$ 2740 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published Date: 2025-04-14
Pages: 83
USD 2900.00
(Single User License)
Percutaneous mechanical circulatory support (PMCS) is a "bridge" technology to wait for cardiac function recovery or to buy time for subsequent treatment, because it is effective in treating patients with cardiac shock or acute decompensated heart failure in the acute stage.
Published Date: 2024-03-12
Pages: 132
USD 4900.00
(Single User License)
Percutaneous mechanical circulatory support (PMCS) is a "bridge" technology to wait for cardiac function recovery or to buy time for subsequent treatment, because it is effective in treating patients with cardiac shock or acute decompensated heart failure in the acute stage.
Published Date: 2024-03-12
Pages: 117
USD 4350.00
(Single User License)
The global Percutaneous Mechanical Circulatory Support Devices market size was US$ 2069 million in 2025 and is forecast to reach a readjusted size of US$ 2858 million by 2032 with a CAGR of 4.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
The global Percutaneous Mechanical Circulatory Support Devices market was valued at US$ 2069 million in 2025 and is anticipated to reach US$ 2858 million by 2032, at a CAGR of 4.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 113
The global market for Percutaneous Mechanical Circulatory Support Devices was estimated to be worth US$ 2069 million in 2025 and is projected to reach US$ 2858 million, growing at a CAGR of 4.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
The global Percutaneous Mechanical Circulatory Support Devices market size was US$ 1984 million in 2024 and is forecast to a readjusted size of US$ 2740 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 80
The global Percutaneous Mechanical Circulatory Support Devices market is projected to grow from US$ 1984 million in 2024 to US$ 2740 million by 2031, at a CAGR of 4.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-08
Pages: 136
The global Percutaneous Mechanical Circulatory Support Devices market is projected to grow from US$ 2069 million in 2025 to US$ 2740 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period.
Published: 2025-04-14
Pages: 137
The global market for Percutaneous Mechanical Circulatory Support Devices was estimated to be worth US$ 1984 million in 2024 and is forecast to a readjusted size of US$ 2740 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published: 2025-04-14
Pages: 94
The global market for Percutaneous Mechanical Circulatory Support Devices was valued at US$ 1984 million in the year 2024 and is projected to reach a revised size of US$ 2740 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published: 2025-04-14
Pages: 83
Percutaneous mechanical circulatory support (PMCS) is a "bridge" technology to wait for cardiac function recovery or to buy time for subsequent treatment, because it is effective in treating patients with cardiac shock or acute decompensated heart failure in the acute stage.
Published: 2024-03-12
Pages: 132
Percutaneous mechanical circulatory support (PMCS) is a "bridge" technology to wait for cardiac function recovery or to buy time for subsequent treatment, because it is effective in treating patients with cardiac shock or acute decompensated heart failure in the acute stage.
Published: 2024-03-12
Pages: 117
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now